Stryker stock falls 21.6 percent as TD Cowen cuts target

Published on 09/22/2026 at 19:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker stock closed at USD 274.19 on September 21, 2026, near its USD 267 52-week low. TD Cowen cut its target to USD 298 from USD 355.

Fotorealistischer OP-Saal mit robotergestützter Chirurgie und sterilen Instrumenten — Fotorealistische Operationssaal-Szene veranschaulicht Stryker Corp. US8636671013 mit robotergestützter Chirurgie und moderner Medizintechnik-Ausstattung, Illustration mit AI erstellt.

Stryker Corp. (ISIN US8636671013) closed at USD 274.19 on the NYSE on September 21, 2026, down 21.6 percent year to date and close to its 52-week low of USD 267. TD Cowen cut its price target from USD 355 to USD 298 while keeping a Hold rating, putting margins and the 2026 outlook at the center of the debate.

TD Cowen lowers its target

According to Investing.com on September 22, 2026, TD Cowen reduced its Stryker target to USD 298 from USD 355 and maintained a Hold rating. The USD 57 reduction is important because it leaves the target only USD 23.81 above the September 21 close.

Another market update from TradingView on September 22, 2026, described the same USD 298 target as implying 8.7 percent upside from the September 21 closing price of USD 274.19. The calculation places the analyst view materially below the broader consensus cited in recent coverage.

Guidance versus estimates

The margin concern is also visible in the 2026 estimates reported by Investing.com on September 22, 2026. TD Cowen expects organic growth of 8.0 percent, below Stryker guidance of 8.3 percent to 9.3 percent, while its EPS estimate of USD 14.92 is below company guidance of USD 14.95 to USD 15.10 and consensus of USD 15.00.

For the third quarter of 2026, TD Cowen estimates revenue of USD 6.625 billion and EPS of USD 3.56, compared with consensus revenue of USD 6.654 billion and EPS of USD 3.57. The revenue gap is USD 29 million and the EPS gap is USD 0.01, so the immediate issue is less a large forecast miss than the pressure on the margin profile behind the target reduction.

Stock remains near yearly low

Stryker stock closed at USD 275.12 on the NYSE on September 21, 2026, down 0.36 percent from the prior session, according to the dated market snapshot. A separate September 22 quotation showed USD 274.19, while the 52-week low was USD 267 and the year-to-date performance was negative 21.6 percent.

The analyst picture is divided. Ad-hoc-News reported on September 21, 2026, that Raymond James reiterated a Buy rating and that a 28-analyst consensus target stood at USD 372.68 against a last close of USD 275.12. That consensus is USD 74.68 above TD Cowen's new target, highlighting the unusually wide spread between published views.

Price stays below USD 300

Stryker stock closed at USD 274.19 on the NYSE on September 21, 2026, with the quoted market data showing a 52-week range from USD 267 to the reported high in the same market overview. The dated figures leave the stock close to the lower end of its annual range while the target revisions place execution and margin delivery ahead of the broader consensus debate.